by European Alliance | Dec 21, 2021 | News
Brussels, 21 December 2021 Members of the Alliance have published a note today outlining key recommendations of civil society organisations for the new EU pharmaceutical strategy. A key pillar for this new strategy is the balance between providing innovation...
by European Alliance | Nov 15, 2021 | News
On Wednesday 17 November (9:30-11:30 am), the Alliance organized the regional dialogue for EU activists working on overcoming patent and other intellectual property barriers to access to health technologies. The dialogue provided a place for EU activists to reflect on...
by European Alliance | Nov 3, 2021 | News
HERA should prioritise the public interest, remain accountable to citizens and ensure equitable and affordable access to medical tools Brussels, 3 November 2021 Several Alliance members have sent a letter to health attachés and to the Health Commissioner urging...
by European Alliance | Sep 21, 2021 | News
Brussels, 20 September 2021 Following the preparation of the next public-private partnership – Innovative Health Initiative – health policy organisations, including several members of the Alliance, have sent a letter to the Health and Research and...
by European Alliance | Sep 9, 2021 | News
Transparency of clinical trials and good governance should be included in the EMA extended mandate Brussels, 9 September 2021 In occasion of the ongoing trilogues on the European Medicines Agency (EMA) extended mandate, Members of the European Alliance for...
by European Alliance | Aug 26, 2021 | News
Brussels, 26 August 2021 As of end of June 2021, Rosa Castro is the new Manager of the European Alliance for responsible R&D and Affordable Medicines, which is hosted by EPHA. Rosa brings her experience working at the intersection of science policy and...
